Supplementary
. Transcriptional and genetic analysis of subclones of 10G cultures stably transfected with plasmid 3.2-LH-bsdR. To determine whether the low level of luc expression in 10G cultures stably transfected with plasmid 3.2-LH-bsdR corresponds to homogeneous low expression in all parasites or variant expression between individual parasites (expression in only some of the parasites), we generated 16 subclones of this transgenic parasite line by limiting dilution. After a screening using luciferase assays (not shown) we selected five subclones with divergent expression levels for more detailed analysis. A. Luciferase activity in four of the selected subclones and the parental stably transfected transgenic line (before subclonning, "Par.") tightly synchronized to 37-44 h post-invasion. Results are expressed in relative light units (RLU) and normalized to 1% parasitemia. Values are the average of two technical replicates, with SEM. B. luc transcript levels (relative to rhoph2) in the five selected subclones and the parental transgenic line. Parasites were analyzed at 37-44 h post-invasion. Values are the average of two independent biological replicates (except for 2H4, n=1), with SEM. C. Relative plasmid copy number in the five selected subclones. Plasmid copy number was determined from gDNA of each parasite line using the luc transgene and normalizing by the single copy gene rhoph2. Values are copy number relative to the parental transgenic line and represent the average of two independent biological replicates (except for 2H4, n=1), with SEM. No large differences in transgene copy number were observed among the subclones. chromosomal integration of the plasmid 3.2-LH-bsdR at the clag3.2 locus. The positions of ClaI restriction sites (C) used for Southern blot analysis are indicated. The red line indicates the position of the probe used for this analysis. The probe was amplified with primers 5'-3.2f and 3.2r0.5 (Supplementary Table S1 ) and recognizes 72 bp upstream of the clag3.2 ATG and the first 177 bp of the coding region. E. Southern blot analysis of the transgenic lines. 3D7-A is a wild type (non-transfected) control. "WT" indicates the position of the expected band in wild type parasites, in the absence of plasmid integration at the clag3 locus (6,716 bp). "Int. 1" and "Int. 2" indicate the bands expected if the plasmid is integrated in the genome via single homologous recombination at the clag3.2 promoter (11,447 and 4,823 bp, respectively, but the smaller band is only weakly recognized by the probe because it contains only 72 bp of the probe sequence). "Epis./mult." indicates the band expected for episomal plasmid or integration of multiple copies of the plasmid (9,554 bp).
Although these cultures were not cycled on/off drug to select for parasites that had integrated the plasmid, integration at the clag3.2 locus occurred in subclones 1A4, 2B6 and 2H4. On the other hand, the clag3.2 locus is intact in subclones 2C10 and 2F12, in which the plasmid is maintained as an episome. Importantly, the plasmid is episomal in the parental transgenic line, indicating that integration occurred mainly during preparation for subclonning. Analysis of the same parasite lines using a probe specific for the luc gene led to similar conclusions (not shown) and excluded plasmid integration at alternative chromosomal locations. The two subclones that do not have the plasmid integrated showed the lowest levels of luc expression, revealing a possible association between the genetic status of the plasmid (episomal or integrated) and its transcriptional activity.
In summary, both luciferase assays and transcriptional analysis showed differences in luc expression among the subclones, in spite of similar plasmid copy number. However, Southern blot analysis revealed that the plasmid had spontaneously integrated in the genome of subclones that showed higher luc expression. Altogether, from these experiments we could not determine whether or not the episomal clag3.2 promoter driving expression of a reporter gene undergoes clonally variant expression controlled at the epigenetic level. Table S1 ) and recognizes 72 bp upstream of the clag3.2 ATG and the first 651 bp of the coding region. This probe also recognizes the clag3.1 coding region. B. Southern blot analysis of 3D7-A cultures transfected with plasmid pHBc3.2 and drug-cycled to select for parasites with integrated plasmid. 3D7-A is a wild type (non-transfected) control, whereas "Par." is the parental transgenic line before subcloning; the other wells correspond to its subclones. The two subclones selected for further analysis are indicated with an asterisk. "WT clag3.1" and "WT clag3.2" indicate the position of the bands expected for the intact clag3.1 and clag3.2 loci, respectively (5,022 and 6,077 bp). "Int. 1" and "Int. 2" indicate the position of the bands expected if the plasmid is correctly integrated via single homologous recombination with the clag3.2 upstream region (6,528 and 7,299 bp, but note that "Int. 2" is poorly recognized by the probe because it contains only 72 bp of the probe sequence). "Epis./Mult." indicates the position of the band expected for episomal plasmid or integration of multiple copies of the plasmid (7,750 bp, also poorly recognized by the probe). This analysis revealed that the plasmid is integrated at the clag3.2 locus in the vast majority of parasites in the parental ("Par.") transgenic line (before subcloning), such that only a very small proportion of the parasites have the intact wild-type locus. All subclones have the plasmid integrated at the clag3.2 upstream region. However, all subclones have integrated multiple copies of the plasmid. C. Southern blot analysis with ClaIdigested gDNA to estimate the number of plasmid copies integrated. Integration of a single copy of the plasmid would yield a band of 14,466 bp, whereas each additional copy would represent an increase in size of 7,750 bp. gDNA of wild type parasites was digested with PvuII + KpnI or SpeI to obtain bands of 17.1 or 23.7 kb, respectively, which facilitated the estimation of the integrated plasmid copy number in the transgenic lines. This analysis revealed that more than three copies of the plasmid are integrated in both the C5 and the G9 subclones. Figure S3 . Integrated plasmid copy number in C5 and G9 subclones maintained for 3 or 6 weeks in the absence or in the presence of WR99210. Plasmid copy number was estimated using two different genes within the plasmid, bsd and hdhfr, with endogenous single copy genes serrs and rhoph2 for normalization. Results are presented as copy number relative to C5 maintained in the absence of WR99210 for 3 weeks. Integrated plasmid copy number is similar between the C5 and G9 subclones. The increased hdhfr and bsd transcript levels associated with drug selection (see main text) cannot be explained by increased gene copy number, because the copy number of these genes is similar between unselected and drug-selected cultures. Values are the average of the determinations of relative integrated plasmid copy number with the two different genes, with SEM. .2 and rhoph2, and the transgenes hdhfr and bsd (driven by a clag3.2 and a hsp90 promoter, respectively) is shown relative to serrs, which is expressed at similar levels throughout the asexual blood cycle. In the two transgenic subclones, hdhfr was expressed only at the schizont stage, similar to endogenous clag3 genes and rhoph2, whereas bsd was expressed at both the schizont and the trophozoite stages, similar to endogenous hsp90 (www.plasmodb.org). Hence, this experiment demonstrates that the promoters in the pHBc3.2 integrated plasmid recapitulate correct stage-specific temporal expression patterns. Differences among samples analyzed at the same stage correspond to epigenetic differences between C5 and G9 or between drug-selected and unselected cultures, as described in the main text. Values are the average of three technical replicates, with SEM. Supplementary Figure S5 . ChIP analysis of BSD-selected parasites in which the two clag3 genes are silenced. The same samples analyzed in Fig. 4 in the main article were used for ChIP analysis with a previously described protocol and antibodies from Millipore that have been extensively used in malaria research (see Materials and Methods). Results are expressed as percentage of chromatin immunoprecipitated with the antibody against H3K9me3 relative to the input sample (% input). Results are also expressed as the ratio of % input for H3K9ac divided by % input for H3K9me3. Values are the average of three independent biological replicates, with SEM. The relatively large error bars are the consequence of different absolute recoveries with different batches of antibodies, but the enrichment patterns were consistent between the three independent experiments.
While the overall pattern observed is the same between the experiments presented here and the experiments in Fig. 4 , the signal to noise ratio is clearly improved with the new protocol and antibodies used in the experiments presented in Fig. 4 . 
